Organigram Global (OGI) Projected to Post Quarterly Earnings on Wednesday

Key Points

• Organigram Global is set to release its Q3 2025 earnings on August 13th, with analysts predicting a loss of ($0.01) per share and expected revenue of $68.04 million.
• The company's stock opened at $1.38 and has a market cap of $184.96 million, with a fifty-two week trading range between $0.85 and $2.08.
• Organigram Global produces and sells cannabis products in Canada, including medical and recreational cannabis under various brand names.

Organigram Global (NASDAQ:OGI - Get Free Report) is expected to release its Q3 2025 earnings data before the market opens on Wednesday, August 13th. Analysts expect Organigram Global to post earnings of ($0.01) per share and revenue of $68.04 million for the quarter.

Organigram Global Trading Up 2.5%

OGI traded up $0.04 during trading on Friday, hitting $1.45. 601,169 shares of the company traded hands, compared to its average volume of 543,081. The company has a market cap of $193.67 million, a PE ratio of 14.45 and a beta of 1.45. The stock's 50-day simple moving average is $1.40 and its two-hundred day simple moving average is $1.27. Organigram Global has a 1 year low of $0.85 and a 1 year high of $2.08.

About Organigram Global

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.